Phase 3 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are between 35 and 55 years old and have not yet gone through menopause (as determined by the research team at the time of joining)
- People whose breast cancer has been confirmed by a tissue sample (biopsy) to be a primary invasive breast cancer
- People whose cancer is at a specific stage — the tumour is larger than 2cm but has not spread to lymph nodes or other parts of the body, and breast-conserving surgery (removing only part of the breast) is not considered possible or would significantly affect the appearance of the breast
- People whose cancer has been confirmed by lab testing to be hormone receptor-positive (meaning the cancer responds to oestrogen or progesterone, with more than 50% of cells showing this) and HER2-negative
- People who have not received any previous treatment for their breast cancer
- People who do not have another active tumour, an unstable serious health condition, or an uncontrolled infection
- People for whom there are no medical reasons preventing the use of a type of hormone-blocking medication called a third-generation aromatase inhibitor (AI), LHRHa (a hormone therapy), or chemotherapy
- People who are willing to take part voluntarily and have signed a consent form
Who may not be able to join:
- People whose cancer has been confirmed by lab testing or imaging to have spread to other parts of the body (metastatic disease)
- People who have a history of another type of cancer
- People for whom there are medical reasons preventing the use of a third-generation aromatase inhibitor (AI), LHRHa, or chemotherapy
- People who have serious heart or blood vessel disease, liver or kidney problems, blood disorders, or other health conditions that make chemotherapy unsafe or unsuitable
- People for whom surgery is not possible — for example, due to risks with anaesthesia, a very large tumour, a tumour classified as T4, or cancer that has spread to the lymph nodes
- People with psychological conditions, mental health disorders, social circumstances, or geographical situations that the research team considers unsuitable for participation
- People who are currently taking part in, or have previously taken part in, another anti-cancer treatment trial
- People who do not wish to take part in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
ultrasound response rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.